Pu.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes

Blood

Volumn 90, Issue 10, 1997, Pages 3984-3995

  Himmelmann, Andreas ^a   Riva, Agostino ^a   Wilson, Gaye Lynn ^a   Lucas, Brian P ^a   Thevenin, Claire ^a   Kehrl, John H ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CIS ACTING ELEMENT; HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING;

EID: 0030780188     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3984     Document Type: Article

References (50)

1. Blackwell TK, Alt FW: Mechanism and developmental program of immunoglobulin gene rearrangement in mammals. Annu Rev Genet 23:605, 1989
2. Calame K, Ghosh S: Regulation of immunoglobulin transcription, in Honjo T, Alt FW, Rabbitts TH (eds): Immunoglobulin Genes. London, UK, Academic Press, 1989, p 397
3. Kehrl JH, Riva A, Wilson GL, Thevenin C: Molecular mechanisms regulating CD 19, CD20 and CD22 gene expression. Immunol Today 15:432, 1994
4. Hagman J, Grosschedl R: Regulation of gene expression at early stages of B cell differentiation. Curr Opin Immunol 6:222, 1994
5. Singh H: Genetic analysis of transcription factors implicated in B lymphocyte development. Immunol Res 13:280, 1994
6. Ernst P, Smale ST: Combinatorial regulation of transcription II: The immunoglobulin μ heavy chain enhancer. Immunity 2:427, 1995
7. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901, 1994
8. Lin H, Grosschedl R: Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263, 1995
9. Zhuang Y, Soriann P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875, 1994
10. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages. Science 265:1573, 1994
11. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143, 1994
12. Nadler LM, Korsmeyer SJ, Anderson KC, Boyd AW, Slaughenhoupt B, Park E, Jansen J, Coral F, Mayer RJ, Sallan SE, Ritz J, Schlossman S: B cell origin of non-T cell acute lymphoblastic leukemia. J Clin Invest 74:332, 1984
13. Tedder TF, Engel P: CD20: A regulator of cell-cycle progression of B lymphocytes. Immunol Today 15:450, 1994
14. Rickmann P, Thevenin C, Wilson GL, Hong JX, Kehrl JH: Analysis of Cis-acting elements present in the CD20/B1 antigen promoter. J Immunol 147:3994, 1991
15. Tedder TF, Klejman G, Schlossman SF, Saito H: Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J Immunol 142:2560, 1989
16. Thevenin C, Lucas BP, Kozlow EJ, Kehrl JH: Cell type-and stage-specific expression of the CD2/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J Biol Chem 268:5949, 1993
17. Corcoran LM, Karvelas M, Nossal GJV, Ye ZS, Jacks T, Baltimore D: Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev 7:570, 1993
18. Mueller PR, Wold B: Ligation mediated PCR for genomic sequencing and footprinting, in Ausubal F (ed): Current Protocols in Molecular Biology. New York, NY, J Wiley and Sons, 1992, p 15.5.1
19. Dignam JE, Martin PI, Shastry BS, Roeder RG: Eukaryotic gene transcription with purified components. Method Enzymol 101:582, 1983
20. Kadesch T: Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today 13:31, 1992
21. Shin MK, Koshland ME: Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Etsbindig element. Genes Dev 7:2006, 1993
22. Pahl HL, Scheibe R, Zhang D, Chen HM, Galson DL, Maki RA, Tenen DG: The proto-oncogene PU.1 regulates expression of the myeloid-specific CD 11b promoter. J Biol Chem 268:5014, 1993
23. Petterson M, Schaffner W: A purine-rich DNA sequence motif present in SV 40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells. Genes Dev 1:962, 1987
24. Eisenbeis CF, Singh H, Storb U: Pip, a novel IRF family member is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9:1377, 1995
25. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the Ets oncogene. Cell 61:113, 1990
26. Moreau-Gachelin F, Tavitian A, Tambourin P: Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature 331:277, 1988
27. Hromas R, Orazi A, Neiman R, Maki R, Van Beveren C, Moore J, Klemsz M: Hematopoietic lineage-and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993
28. Moreau-Gachelin F: Spi-1/Pu.l: An oncogene of the Ets family. Biochim Biophys Acta 1198:149, 1994
29. Eisenbeis CF, Singh H, Storb U: PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin 2-4 enhancer. Mol Cell Biol 13:6452, 1993
30. Hagemeier C, Bannister AJ, Cook A, Kouzarides T: The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90:1580, 1993
31. Nagulapalli S, Pongubala JM, Atchison ML: Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3). J Immunol 155:4330, 1995
32. Pongubala JR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchinson ML: PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ3′ enhancer activity. Mol Cell Biol 12:368, 1992
33. Pongubala JM, VanBeveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML: Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622, 1993
34. Driggers P, Ennist D, Gleason S, Mak WH, Marks M, Levi BZ, Flanagan J, Appella E, Ozato K: An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci 87:3743, 1990
35. Nelson N, Marks M, Driggers P, Ozato K: Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family suppresses interferon-in-induced gene transcription. Mol Cell Biol 16:694, 1993
36. Brass AL, Kehrli E, Eisenbeis CF, Storb U, Singh H: Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev 10:2335, 1996
37. Pettersson M, Sundstrom C, Nilsson K, Larsson LG: The hematopoietic transcription factor PU. 1 is downregulated in human multiple myeloma cell lines. Blood 86:2747, 1995
38. Nelsen B, Tian G, Eman B, Gregoire J, Maki R, Graves B, Sen R: Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. Science 261:82, 1993
39. Crepieux P, Coll J, Stehelin D: The Ets family of proteins: Weak modulators of gene transcription in quest for transcriptional partners. Crit Rev Oncol 5:615, 1994
40. Church GM, Ephrussi A, Gilbert W, Tonegawa S: Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature 313:798, 1985
41. Ephrussi A, Church GM, Tonegawa S, Gilbert W: B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134, 1985
42. Beckmann H, Su L-K, Kadesch T: TFE3: A helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes Dev 4:167, 1990
43. Roman C, Matera G, Cooper C, Artandi S, Blain S, Ward D, Calame K: mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol 12:817, 1992
44. Lenardo M, Pierce JW, Baltimore D: Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236:1573, 1987
45. Gregor P, Sawadogo M, Roeder R: The adenovirus major late transcription factor USE is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev 4:1730, 1990
46. Carr C, Sharp PA: A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol Cell Biol 10:4384, 1990
47. Chodosh LA, Carthew RW, Morgan JG, Crabtree GR, Sharp PA: The adenovirus major late transcription factor activates the rat-γ fibrinogoen promoter. Science 238:684, 1987
48. Cogswell JP, Godlevski MM, Bonham M, Bisi J, Babiss L: Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter. Mol Cell Biol 15:2782, 1995
49. Reisman D, Rotter V: The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res 21:345, 1993
50. Artandi SE, Cooper C, Shrivastava A, Calame K: The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction. Mol Cell Biol 14:7704, 1994